<?xml version="1.0" encoding="UTF-8"?>
<p>Health impact costs were assessed in two ways. First of all, we estimated the medical costs for all imported cases of dengue, chikungunya and Zika virus in Greece for the period 2013–2017 (
 <xref rid="pntd.0007467.t001" ref-type="table">Table 1</xref>). This calculation was based on anonymized data on the duration of hospitalization of reported cases, including intensive care treatment, provided through the official records of NPHO. It should be noted that the reported cases consisted mainly of infected travelers from chikungunya, dengue and Zika endemic countries who presented symptoms of these diseases upon their return to Greece. These estimates of medical costs are similar to those in the recent literature regarding the imported chikungunya cases in Italy (based on 2015 data), and the 2005–2006 chikungunya epidemic in La Reunion [
 <xref rid="pntd.0007467.ref022" ref-type="bibr">22</xref>, 
 <xref rid="pntd.0007467.ref023" ref-type="bibr">23</xref>].
</p>
